Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a cataract that can be treated with surgery, where even with glasses or contact lenses their vision is still 20/40 or worse (meaning they would struggle to read a standard eye chart clearly)
- People who have been diagnosed with a common type of glaucoma called primary open angle glaucoma, and are currently managing it with no more than 4 eye drop medications to lower eye pressure
- People whose optic nerve (the nerve at the back of the eye) shows signs that are typical of glaucoma
- People whose eye pressure, while on medication, is 31 mmHg or below (mmHg is the unit used to measure pressure inside the eye)
Who may not be able to join:
- People who have a type of glaucoma where the drainage angle in the eye is closed or narrow (rather than open)
- People who were born with glaucoma or developed it during childhood
- People whose glaucoma was caused by another medical condition or eye problem (known as secondary glaucoma)
- People currently using more than 4 eye pressure-lowering medications
- People who have previously had certain laser or surgical treatments for glaucoma, including laser trabeculoplasty, trabeculectomy, tube shunts, or other similar drainage or pressure-reducing eye surgeries
- People who have previously had surgery that involved implanting a device into, or otherwise operating on, specific drainage structures inside the eye (confirm with trial site)
- There may be additional criteria not listed here that the trial site will assess
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Project Lead, CDMA Surgical, Alcon Research
Phone: 1-888-451-3937
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of occurrence of clinically significant device malposition associated with clinical sequelae
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.